Kennedy Investment Group Bristol Myers Squibb CO Transaction History

Kennedy Investment Group

  • $197 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 19, 2023
BUY
$63.71 - $70.74 $1,210 - $1,344
19 Added 0.57%
3,338 $213 Million
Q1 2023

May 31, 2023
BUY
$65.71 - $74.53 $1,577 - $1,788
24 Added 0.73%
3,319 $230 Million
Q4 2022

May 31, 2023
BUY
$68.48 - $81.09 $225,641 - $267,191
3,295 New
3,295 $237 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kennedy Investment Group Portfolio

Follow Kennedy Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Investment Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email